Aug 2026· Pharmacia· Vol 73· 0 citations· 73 references
TL;DR
Continuous progress in research strategies for synthesizing iNPs with optimal properties while minimizing adverse effects on living cells is a prerequisite for even greater translational potential of iNP-based DDSs.
Abstract
Aim
: Over the past decade, nanomedicine has made significant progress in the development of inorganic nanoparticle (iNP)-based drug delivery systems (DDSs). The aim of this narrative review is to summarize the most recent developments in iNP systems, emphasize their advantages as DDSs, and provide detailed commentary on their impact on human health. A systematic search was performed in the PubMed, Scopus, and Web of Science databases for peer-reviewed original research and review articles published between 2020 and 2025. Relevant scientific data on innovative applications of iNPs in cancer therapy were reviewed. The enormous potential of magnetic nanoparticles (NPs), metal–organic frameworks (MOFs), and iNPs used as carriers of small interfering RNAs (siRNAs) as innovative strategies for enhancing antitumor treatment is highlighted.
Conclusion
: Continuous progress in research strategies for synthesizing iNPs with optimal properties while minimizing adverse effects on living cells is a prerequisite for even greater translational potential of iNP-based DDSs.
Advances in nanotechnology have produced a range of strategies for cancer treatment. Among the materials under investigation, Gold Nanoparticles (AuNPs) are attractive candidates for immunotherapy because of their distinctive physicochemical properties and biocompatibility.
This narrative review draws on stu...
V. R. Jallepalli, Angum M. M. Ibrahim, Anasuya Patil et al.· Current Nanomedicine· 0 citations
The review gives a general description of drug delivery systems that are based on nanotechnology, with liposomes, polymeric nanoparticles, dendrimers, solid lipid nanoparticles, and metallic nanoparticles being the main examples of nanocarriers.
Shalini Tiwari, S. Kotnala, Rohinee Bhandari et al.· Trends in Biomaterials & Art...· 0 citations
Nanotechnology has emerged as a promising avenue for producing nanomedicines as alternatives to conventional drugs. Many organic nanoparticles, such as liposomes used in formulations like Doxil, Onivyde, and Marqibo, are approved by the Food and Drug Administration (FDA) and instrumental in treating various types of ca...
Frank Ssengooba, J. Andrew, Donald Fernandes· Drug development research (P...· 0 citations
The current role of green-synthesized NPs in renal cell carcinoma management and their applications in targeted drug delivery and cancer-specific targeting mechanisms are focused on and the environmentally friendly green synthesis approaches utilizing biological resources such as plant extracts and microorganisms are h...
Mariam R. Khalifa, Doaa S. R. Khafaga, Marwa T. Abo Gabal et al.· International Journal of Mol...· 0 citations
INTRODUCTION
Innovative drug delivery systems are required to improve the therapeutic efficacy of cancer, which continues to be a global health challenge. Gelatin-based nanocarriers provide a prospective platform for targeted cancer therapy by utilizing their biocompatibility and stimuli-responsive properties, thereby...
Lalit Kumar, Vikas Aggarwal, Komal Komal et al.· Anti-Cancer Agents in Medici...· 0 citations
Nanotechnology has emerged as a transformative frontier for detecting and treating various types of tumours more accurately. As a leading technology, nanotechnology assists in overcoming the issues linked with traditional antitumor drug systems. Nanocarriers (NCs) are colloidal systems developed for precise drug delive...
Shalu Tiwari, Abhijeet Ojha, A. Singh et al.· Journal of Drug Delivery and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
